Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rozerem in Migraine Headaches
NCT00391755Phase 4Terminated
- Start
- Oct 2006
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in migraine comparing Rozerem with Placebo (2 arms). Primary endpoint: Reduction in migraine headaches at 4 months. Started Oct 2006; status: terminated.
02
Drugs
ramelteon
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00391755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00391755.